Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    "Oncogenic osteomalacia"
Show Display Options
Rank Status Study
1 Recruiting 68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
Conditions: Oncogenic Osteomalacia;   Mesenchymal Tumor
Intervention: Drug: 68Ga-DOTATATE
2 Recruiting Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
Condition: Hypophosphatemia
Intervention:
3 Completed Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia
Conditions: Osteomalacia;   Neoplasms
Intervention:
4 Recruiting Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition: Osteomalacia
Intervention: Drug: Osteomalacia

Indicates status has not been verified in more than two years